Form 8-K - Current report:
SEC Accession No. 0001144204-11-000445
Filing Date
2011-01-04
Accepted
2011-01-04 15:53:55
Documents
13
Period of Report
2010-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v207089_8k.htm 8-K 129045
2 v207089_ex2-1.htm EX-2.1 420800
3 v207089_ex2-2.htm EX-2.2 44483
4 v207089_ex3-1.htm EX-3.1 135177
5 v207089_ex4-1.htm EX-4.1 275864
6 v207089_ex4-2.htm EX-4.2 90640
7 v207089_ex4-3.htm EX-4.3 171507
8 v207089_ex4-4.htm EX-4.4 78278
9 v207089_ex4-5.htm EX-4.5 73512
10 v207089_ex10-1.htm EX-10.1 78023
11 v207089_ex10-2.htm EX-10.2 67182
12 v207089_ex10-3.htm EX-10.3 118438
13 v207089_ex99-1.htm EX-99.1 13007
  Complete submission text file 0001144204-11-000445.txt   1698030
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30975 | Film No.: 11505643
SIC: 3826 Laboratory Analytical Instruments